PD-1 MOUNTAINEER: Open-label, phase 2 study of tucatinib combined with trastuzumab for HER2-positive metastatic colorectal cancer (SGNTUC-017, trial in progress)
Conference Paper
Full Text
Duke Authors
Cited Authors
- Siena, S; Elez, E; Peeters, M; André, T; Van den Eynde, M; Ng, K; Cercek, A; Fountzilas, C; Sanchez, F; Hubbard, J; Wu, C; Tabernero, J; Kardosh, A; Saeed, A; Strickler, J; Bekaii-Saab, T; Stecher, M; Palanca-Wessels, M; Van Cutsem, E
Published Date
- July 2021
Published In
Volume / Issue
- 32 /
Start / End Page
- S199 - S199
Published By
International Standard Serial Number (ISSN)
- 0923-7534
Digital Object Identifier (DOI)
- 10.1016/j.annonc.2021.05.019